Democratizing Drug Discovery with an Orchestrated, Knowledge-Driven Multi-Agent Team for User-Guided Therapeutic Design

• URL: http://arxiv.org/abs/2512.21623v1
• Date: Thu, 25 Dec 2025 11:03:04 GMT
• Title: Democratizing Drug Discovery with an Orchestrated, Knowledge-Driven Multi-Agent Team for User-Guided Therapeutic Design
• Authors: Takahide Suzuki, Kazuki Nakanishi, Takashi Fujiwara, Hideyuki Shimizu,
• Abstract summary: OrchestRA is a human-in-the-loop multi-agent platform that unifies biology, chemistry, and pharmacology.<n>Unlike static code generators, our agents actively execute simulations and reason the results to drive iterative optimization.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Therapeutic discovery remains a formidable challenge, impeded by the fragmentation of specialized domains and the execution gap between computational design and physiological validation. Although generative AI offers promise, current models often function as passive assistants rather than as autonomous executors. Here, we introduce OrchestRA, a human-in-the-loop multi-agent platform that unifies biology, chemistry, and pharmacology into an autonomous discovery engine. Unlike static code generators, our agents actively execute simulations and reason the results to drive iterative optimization. Governed by an Orchestrator, a Biologist Agent leverages deep reasoning over a massive knowledge graph (>10 million associations) to pinpoint high-confidence targets; a Chemist Agent autonomously detects structural pockets for de novo design or drug repositioning; and a Pharmacologist Agent evaluates candidates via rigorous physiologically based pharmacokinetic (PBPK) simulations. This architecture establishes a dynamic feedback loop where pharmacokinetic and toxicity profiles directly trigger structural reoptimization. By seamlessly integrating autonomous execution with human guidance, OrchestRA democratizes therapeutic design, transforming drug discovery from a stochastic search to a programmable evidence-based engineering discipline.

Related papers

• Mozi: Governed Autonomy for Drug Discovery LLM Agents [21.429647382651677]
  In dependency-heavy pharmaceutical pipelines, autonomous agents often drift into irreproducible trajectories.<n>We present Mozi, a dual-layer architecture that bridges the flexibility of generative AI with the deterministic rigor of computational biology.<n>We demonstrate Mozi's ability to navigate massive chemical spaces, enforce stringent toxicity filters, and generate highly competitive in silico candidates.
  arXiv  Detail & Related papers  (2026-03-04T02:22:21Z)
• MedSAM-Agent: Empowering Interactive Medical Image Segmentation with Multi-turn Agentic Reinforcement Learning [53.37068897861388]
  MedSAM-Agent is a framework that reformulates interactive segmentation as a multi-step autonomous decision-making process.<n>We develop a two-stage training pipeline that integrates multi-turn, end-to-end outcome verification.<n>Experiments across 6 medical modalities and 21 datasets demonstrate that MedSAM-Agent achieves state-of-the-art performance.
  arXiv  Detail & Related papers  (2026-02-03T09:47:49Z)
• Bohrium + SciMaster: Building the Infrastructure and Ecosystem for Agentic Science at Scale [82.20980951765891]
  We argue that scaling agentic science requires an infrastructure-and-ecosystem approach, instantiated Bohrium+SciMaster.<n>Bohrium acts as a managed, traceable hub for AI4S assets that turns diverse scientific data, software, compute, and laboratory systems into agent-ready capabilities.<n>SciMaster orchestrates these capabilities into long-horizon scientific, on which scientific agents can be composed and executed.
  arXiv  Detail & Related papers  (2025-12-23T16:04:41Z)
• Simple Agents Outperform Experts in Biomedical Imaging Workflow Optimization [69.36509281190662]
  Adapting production-level computer vision tools to bespoke scientific datasets is a critical "last mile" bottleneck.<n>We consider using AI agents to automate this manual coding, and focus on the open question of optimal agent design.<n>We demonstrate that a simple agent framework consistently generates adaptation code that outperforms human-expert solutions.
  arXiv  Detail & Related papers  (2025-12-02T18:42:26Z)
• SelfAI: Building a Self-Training AI System with LLM Agents [79.10991818561907]
  SelfAI is a general multi-agent platform that combines a User Agent for translating high-level research objectives into standardized experimental configurations.<n>An Experiment Manager orchestrates parallel, fault-tolerant training across heterogeneous hardware while maintaining a structured knowledge base for continuous feedback.<n>Across regression, computer vision, scientific computing, medical imaging, and drug discovery benchmarks, SelfAI consistently achieves strong performance and reduces redundant trials.
  arXiv  Detail & Related papers  (2025-11-29T09:18:39Z)
• FRAGMENTA: End-to-end Fragmentation-based Generative Model with Agentic Tuning for Drug Lead Optimization [1.5866079116942815]
  FRAGMENTA is an end-to-end framework for drug lead optimization.<n>It includes a novel generative model that reframes fragmentation as a "vocabulary selection" problem.<n>It also includes an agentic AI system that refines objectives via conversational feedback from domain experts.
  arXiv  Detail & Related papers  (2025-11-25T17:17:54Z)
• AutoLabs: Cognitive Multi-Agent Systems with Self-Correction for Autonomous Chemical Experimentation [0.10999592665107412]
  AutoLabs is a self-correcting, multi-agent architecture designed to autonomously translate natural-language instructions into executable protocols.<n>We present a comprehensive evaluation framework featuring five benchmark experiments of increasing complexity.<n>Our results demonstrate that agent reasoning capacity is the most critical factor for success.
  arXiv  Detail & Related papers  (2025-09-30T01:51:46Z)
• Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle [0.0]
  This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents.<n>Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight.
  arXiv  Detail & Related papers  (2025-07-11T21:13:13Z)
• Chemist-X: Large Language Model-empowered Agent for Reaction Condition Recommendation in Chemical Synthesis [55.30328162764292]
  Chemist-X is a comprehensive AI agent that automates the reaction condition optimization (RCO) task in chemical synthesis.<n>The agent uses retrieval-augmented generation (RAG) technology and AI-controlled wet-lab experiment executions.<n>Results of our automatic wet-lab experiments, achieved by fully LLM-supervised end-to-end operation with no human in the lope, prove Chemist-X's ability in self-driving laboratories.
  arXiv  Detail & Related papers  (2023-11-16T01:21:33Z)
• Active Predicting Coding: Brain-Inspired Reinforcement Learning for Sparse Reward Robotic Control Problems [79.07468367923619]
  We propose a backpropagation-free approach to robotic control through the neuro-cognitive computational framework of neural generative coding (NGC) We design an agent built completely from powerful predictive coding/processing circuits that facilitate dynamic, online learning from sparse rewards. We show that our proposed ActPC agent performs well in the face of sparse (extrinsic) reward signals and is competitive with or outperforms several powerful backprop-based RL approaches.
  arXiv  Detail & Related papers  (2022-09-19T16:49:32Z)
• Artificial Intelligence based Autonomous Molecular Design for Medical Therapeutic: A Perspective [9.371378627575883]
  Domain-aware machine learning (ML) models have been increasingly adopted for accelerating small molecule therapeutic design. We present the most recent breakthrough achieved by each of the components, and how such autonomous AI and ML workflow can be realized.
  arXiv  Detail & Related papers  (2021-02-10T00:43:46Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.